Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma.

导出 LinkOut

翻译打印收藏纠错

作者： Morgan,Homan ^[1] ; Govind,Warrier ^[2] ; Christopher D,Lao ^[3] ; Sarah,Yentz ^[2] ; Shawna,Kraft ^[1] ; Leslie A,Fecher ^[3]

作者单位： Department of Pharmacy, University of Michigan, Ann Arbor, MI, United States. ^[1] Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States. ^[2] Department of Internal Medicine and Dermatology, University of Michigan, Ann Arbor, MI, United States. ^[3]

关键词 BRAF MEK inhibitor melanoma pyrexia toxicity

DOI 10.3389/fonc.2022.855794

PMID 36212431

发布时间 2022-10-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览3

Frontiers in oncology

2022年12卷

855794页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除